Northern Trust
RNXT icon

Northern Trust’s RenovoRx RNXT Stock Holding History

Northern Trust’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.5K Buy
85,207
+43,046
+102% +$39.1K ﹤0.01% 4166
2026
Q1 		$42.6K Hold
42,161
– – ﹤0.01% 4268
2025
Q4 		$35.4K Hold
42,161
– – ﹤0.01% 4335
2025
Q3 		$53.5K Buy
42,161
+15,385
+57% +$18.3K ﹤0.01% 4276
2025
Q2 		$35.2K Hold
26,776
– – ﹤0.01% 4288
2025
Q1 		$26.5K Buy
+26,776
New +$31.2K ﹤0.01% 4311

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Northern Trust's RNXT Position: Q2 2026 in Review

Northern Trust increased its RenovoRx (RNXT) stake by 102% in Q2 2026, buying an estimated $39.1K and bringing the position to 85,207 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4166.

Northern Trust first reported a position in RNXT in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Northern Trust held 85,207 shares of RenovoRx worth $83.5K as of Q2 2026.
  • Northern Trust bought 43,046 RenovoRx shares in Q2 2026, an estimated $39.1K.
  • RenovoRx made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4166 holding.
  • Northern Trust first reported a position in RenovoRx in Q1 2025 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.